Practical Implementation of Diabetes Technology: Real-World Use.

Abstract

We are currently experiencing a “golden age” of diabetes technology: small, accurate, easy‐to‐use CGMs may soon render blood glucose testing obsolete, while pumps are increasingly integrated with sensors to automate insulin delivery for better glycemic results. Nevertheless, the data clearly demonstrate that devices alone will not improve diabetes outcomes: for these technologies to truly, positively impact outcomes, people with diabetes must have access to the devices and supplies without undue financial burden, as well as the educational support necessary to effectively integrate them into their own self‐management practices. As these technologies are increasingly adopted into routine care for more people with T1D and T2D, the widespread use of automated decision support can potentially offset and reduce overall healthcare costs by improving outcomes with more efficient investment of clinical resources.